approval
saveRIFADIN (RIFAMPIN) — FDA approval
community read0 votes
Sponsor: SANOFI AVENTIS US. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalRIFADIN (RIFAMPIN) — FDA approvalDec 5, 2025 · 299d ago
- approvalRIFADIN (RIFAMPIN) — FDA approvalDec 5, 2025 · 299d ago
- approvalRIFADIN (RIFAMPIN) — FDA approvalOct 8, 2025 · 357d ago
- approvalRIFADIN (RIFAMPIN) — FDA approvalOct 8, 2025 · 357d ago
- approvalRIFADIN (RIFAMPIN) — FDA approvalOct 10, 2024 · 720d ago
- approvalRIFADIN (RIFAMPIN) — FDA approvalOct 10, 2024 · 720d ago
- approvalRIFADIN (RIFAMPIN) — FDA approvalDec 8, 2023 · 1027d ago
- approvalRIFADIN (RIFAMPIN) — FDA approvalDec 8, 2023 · 1027d ago
same company · ±60 days · 1
🐶 often sniffed alongside
top 8- tagApproval464 co-mentions · 116 sources
- drugrifampin235 co-mentions · 119 sources
- company$SNYSanofi233 co-mentions · 117 sources
- company$SNYNFSanofi233 co-mentions · 117 sources
- tagSmall Molecule176 co-mentions · 88 sources
- tagDrug Shortage3 co-mentions · 3 sources
- companyMylan Institutional Inc1 co-mentions · 1 sources
- companyEpic Pharma LLC1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that